71980-98-8

• 常用中文名：伪单胞菌酸C
• 常用英文名：Pseudomonic Acid C
• CAS号：71980-98-8
• 分子式：C₂₆H₄₄O₈
• 分子量：484.62
• 相关类别： 信号通路 抗感染 细菌
• 发布时间：2016-01-02 03:02:12
• 更新时间：2026-07-14 20:00:49
• 假单胞菌酸C是一种抗生素,具有抗菌活性[1]。

名称

• 中文名: 伪单胞菌酸C
• 英文名: 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
• 中文别名: 莫匹罗星钙杂质2; 莫匹罗星钙杂质B; 假单胞菌酸 C; 莫匹罗星杂质B; 莫匹罗星杂质2(莫匹罗星杂质B); 假单胞酸C
• 英文别名: Mupirocin calcium impurity B; 9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-Dihydroxy-5β-[(2E,4S,5S)-5-hydroxy-4-methyl-2-hexenyl]tetrahydro-2H-pyran]-2β-yl]-3-methyl-2-butenoyl]oxy]nonanoic acid; Mupirocin Impurity 2(Mupirocin Impurity B); L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[(2E,4R,5S)-5-hydroxy-4-methyl-2-hexen-1-yl]-3-methyl-, 8-cboxyoctyl ester, (2E); Mupirocin calcium impurity B [EP]; UNII-O6M926DF2R; 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-((4R,5S,E)-5-hydroxy-4-methylhex-2-en-1-yl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid; Mupirocin Impurity B/Pseudomonic Acid C/9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]nonanoic acid; Mupirocin Impurity-B / Pseudomonic acid Impurity-C; (+)-pseudomonic acid C; Pseudomonas C; Mupirocin Calcium Impurity 2(Mupirocin Calcium Impurity B); L-TALO-NON-2-enonic acid,5,9-anhydro-2,3,4,8-tetradeoxy-8-(5-hydroxy-4-methyl-2-hexen-1-yl)-3-methyl-,8-carboxyoctyl ester,(2E); Mupirocin Caclium Impurity B; 9-(((2E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-((2E,4R,5S)-5-hydroxy-4-methylhex-2-enyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid

物化性质

• 密度: 1.125g/cm3
• 沸点: 656.193ºC at 760 mmHg
• 分子式: C₂₆H₄₄O₈
• 分子量: 484.62
• 闪点: 210.281ºC
• 精确质量: 484.30400
• PSA: 133.52000
• LogP: 3.38130
• 折射率: 1.516

生物活性

• 描述: 假单胞菌酸C是一种抗生素,具有抗菌活性[1]。
• 相关类别:
  研究领域 >> 感染
  信号通路 >> 抗感染 >> 细菌
• 参考文献:

  [1]. R Sutherland, et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985 Apr;27(4):495-8.

合成路线